Patents by Inventor Christopher Robin Dalton

Christopher Robin Dalton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Naphthamidine urokinase inhibitors
    Patent number: 6495562
    Abstract: Compounds having the formula are inhibitors of urokinase and are useful in the treatment of diseases in which urokinase plays a role. Also disclosed are urokinase-inhibiting compositions, methods for the preparation of urokinase-inhibitors, and a method of inhibiting urokinase in a mammal.
    Type: Grant
    Filed: April 25, 2001
    Date of Patent: December 17, 2002
    Assignee: Abbott Laboratories
    Inventors: Milan Bruncko, Christopher Robin Dalton, Vincent Louis Giranda, Jianchun Gong, Willian J. McClellan, Vicki L. Nienaber, Todd Warren Rockway, Daryl Richard Sauer, Moshe Weitzberg
  • Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
    Patent number: 5922737
    Abstract: The present invention relates to novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl )benzamide derivatives of the formula: ##STR1## stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonists. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
    Type: Grant
    Filed: January 6, 1997
    Date of Patent: July 13, 1999
    Assignee: Hoechst Marion Roussel, Inc.
    Inventors: George Daniel Maynard, John Michael Kane, Braulio Santiago, Elizabeth Mary Kudlacz, Larry Don Bratton, Christopher Robin Dalton
  • 3-phenyl-1,4-dialkyl-1,2,4-triazolium salts and their use as antidepressants
    Patent number: 5856350
    Abstract: This invention relates to the treatment of depression by administration of novel 3-(R.sub.n -phenyl)-1,4-dialkyl-1,2,4-triazolium salts of the formula ##STR1## wherein R is halogen, trifluoromethyl, C.sub.1-4 lower alkyl or C.sub.1-4 lower alkoxy,n is zero, 1 or 2, andR.sub.1 and R.sub.4 independently represent C.sub.1-3 lower alkyl;and A.sup.- represents a pharmaceutically acceptable anion.
    Type: Grant
    Filed: December 13, 1996
    Date of Patent: January 5, 1999
    Assignee: Hoechst Marion Roussel, Inc.
    Inventors: Christopher Robin Dalton, John Michael Kane, John Herr Kehne